Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tullio Florio

Showing results (21-30 of 180) with videos related to

Pageof 18
Sort By:
Frontiers in Cellular Neuroscience|June 7, 2014
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironmentRoberto Würth, Adriana Bajetto, Jeffrey K Harrison, et al.
Stem Cells Translational Medicine|June 17, 2020
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversiesAdriana Bajetto, Stefano Thellung, Irene Dellacasagrande, et al.
International Journal of Molecular Sciences|April 30, 2021
An Overview of Long Non-Coding (lnc)RNAs in NeuroblastomaFrancesca Baldini, Matilde Calderoni, Laura Vergani, et al.
Cancer Cell International|August 15, 2014
Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNADelfina Costa, Arianna Gigoni, Roberto Würth, et al.
Toxicology Letters|March 12, 2003
Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferationRudy Bonavia, Adriana Bajetto, Simone Barbero, et al.
Journal of Molecular Endocrinology|March 7, 2007
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary functionFederica Barbieri, Adriana Bajetto, Carola Porcile, et al.
Neuro-Degenerative Diseases|June 29, 2007
Amyloid precursor protein and presenilin involvement in cell signalingValentina Venezia, Mario Nizzari, Pia Carlo, et al.
Drug Discovery Today|October 13, 2015
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compoundsRoberto Würth, Stefano Thellung, Adriana Bajetto, et al.
Frontiers in Neuroscience|September 23, 2022
Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targetsStefano Thellung, Alessandro Corsaro, Irene Dellacasagrande, et al.
Omics : a Journal of Integrative Biology|February 11, 2012
Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicityAlessandro Corsaro, Stefano Thellung, Valentina Villa, et al.
Pageof 18

Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
Frontiers in Cellular Neuroscience|June 7, 2014
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironmentRoberto Würth, Adriana Bajetto, Jeffrey K Harrison, et al.
Stem Cells Translational Medicine|June 17, 2020
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversiesAdriana Bajetto, Stefano Thellung, Irene Dellacasagrande, et al.
International Journal of Molecular Sciences|April 30, 2021
An Overview of Long Non-Coding (lnc)RNAs in NeuroblastomaFrancesca Baldini, Matilde Calderoni, Laura Vergani, et al.
Cancer Cell International|August 15, 2014
Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNADelfina Costa, Arianna Gigoni, Roberto Würth, et al.
Toxicology Letters|March 12, 2003
Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferationRudy Bonavia, Adriana Bajetto, Simone Barbero, et al.
Journal of Molecular Endocrinology|March 7, 2007
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary functionFederica Barbieri, Adriana Bajetto, Carola Porcile, et al.
Neuro-Degenerative Diseases|June 29, 2007
Amyloid precursor protein and presenilin involvement in cell signalingValentina Venezia, Mario Nizzari, Pia Carlo, et al.
Drug Discovery Today|October 13, 2015
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compoundsRoberto Würth, Stefano Thellung, Adriana Bajetto, et al.
Frontiers in Neuroscience|September 23, 2022
Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targetsStefano Thellung, Alessandro Corsaro, Irene Dellacasagrande, et al.
Omics : a Journal of Integrative Biology|February 11, 2012
Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicityAlessandro Corsaro, Stefano Thellung, Valentina Villa, et al.
Pageof 18